Monday, 5 June 2023

Lupin:

Lupin: The pharma major has launched Darunavir tablets, in 600 mg and 800 mg strength, to market a generic equivalent of Prezista tablets of Janssen Products, LP, which reduces the amount of HIV in the blood. Darunavir tablets had estimated annual sales of $308 million in the US, as per IQVIA MAT March 2023.
at
Labels: , ,

India Daybook – Stocks in News

*P&G:* Net profit up 36.5% Rs 210.7 cr, Revenue up 8.9% at Rs 1,138.4 cr YoY  *TVS Motors:* Net profit at Rs 536.6 cr vs poll Rs 520.0 c...

  • Bank of India
    The public sector lender has revised its marginal cost of fund-based lending rate (MCLR) with effect from November 1 in terms of the pricing...
  • Procter & Gamble
    he FMCG company has reported a 36 percent on-year growth in net profit at Rs 211 crore for the quarter ended September FY24 (Q1 FY24), led b...
  • India's Q4FY23 GDP growth
    India's Q4FY23 GDP growth rate was 6.1%, compared to the projected 5% growth. Q1 was 13.5%. Q2 was 6.3%. Q3 was 4.4%. The RBI's FY23...